| Xcovery is aggressively developing eight promising programs
in oncology and inflammation. Xcovery's approach and experience
in kinase therapeutics facilitates rapid discovery, with
one of the shortest paths from drug discovery to pre-clinical
development in the industry. |
|
|
 |
| |
|